Journal of Pharmacogenomics & Pharmacoproteomics

Toshihisa Ishikawa

Toshihisa Ishikawa
Professor, Biochemistry and Molecular Biology, RIKEN Yokohama Institute
Japan

Biography

Toshihisa Ishikawa obtained the PhD degree from the Graduate School of Science Hokkaido University, Japan in March 1982. In the same year he received the scholarship of the Deutscher Akademischer Austauschdienst and moved to West Germany From 1982 till 1987. He was a Postdoctoral Fellow at the Institute of Physiological Chemistry Medical School of University Dusseldorf in Germany. In April 1987 he came back to Japan and was appointed to Assistant Biochemist at the Department of Biochemistry Medical School of Osaka University, Japan. In 1989 he became the Project Leader of the Department of Tumor Biochemistry at German Cancer Research Institute in Heidelberg. In 1991 Dr. Ishikawa left Germany for the USA and was appointed to an Assistant Professor at the Department of Experimental Pediatrics, University of Texas, MD, Anderson Cancer Center in Huston, Texas, USA. In addition he had an adjunct appointment of Assistant Professor at the Graduate School of Health Science Center University of Texas. In 1993 he received a research award from the International Life Sciences Institute Washington DC. In December 1995 he was appointed to the Senior Scientist and Manager at the Department of Medicinal Biology in the Central Research of Pfizer Pharmaceuticals Inc. and thereafter became the Director of the Department of Research Technology Development at the Japanese Headquarters of Pfizer Pharmaceuticals Inc. in Tokyo in 1999. From 2000 till May 2009 Dr. Ishikawa was a Professor at the Graduate School of Bioscience and Biotechnology Tokyo Institute of Technology, Japan. He is presently a Professor and directing the Pharmacogemics Project at the Omics Science Center in RIKEN Yokohama Institute. Dr. Ishikawa is a Member of the International Nomenclature Committee for Human ABC Transporter Genes. Most recently he was one of the Steering Committee Members to organize the FDA Critical Path Transporter Workshop held in Bethesda, MD, USA in October 2 and 3, 2008.

Research Interest

Medical science, biology.